Search | Page 35 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  This study is a research study involving subjects who are diagnosed with a malignant disease, ...

    Clinical Trial last updated 05/03/2016 - 10:47am.

  2. Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s ... (SCT) between 3 to 15 months after the SCT. In this research study, researchers want to find how well dasatinib can be tolerated, ...

    Clinical Trial last updated 05/03/2016 - 10:43am.

  3. Prognostic value of telomere attrition in patients with aplastic anemia

    ... measurements are another example of a potentially useful clinical marker to predict outcome in patients with SAA.  Telomeres are ... is ongoing.    In summary, it is an active area of research to utilize TL measurements in the decision making for patients with ...

    Research Review last updated 05/02/2016 - 9:25am.

  4. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s ... ) Each patient must be willing to participate as a research subject and must sign an informed consent form.   Donor ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  5. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  This research is being done to learn more about nonmyeloablative bone marrow ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.

  6. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  This research is looking at two conditions, Essential Thrombocythemia (ET) and ...

    Clinical Trial last updated 05/02/2016 - 2:31pm.

  7. Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  The aim of this research is to look at two conditions, Essential Thrombocythemia (ET) and ...

    Clinical Trial last updated 04/29/2016 - 9:59am.

  8. Clofarabine in the treatment of myelodysplastic syndromes

    ... patients with MDS and acute myeloid leukemia (AML).  Early research studies identified 40 mg/m2 daily for 5 days per course as the ... cell transplantation in patients with MDS. Additional clinical trials are needed to define which patients derive the most benefit ...

    Research Review last updated 05/02/2016 - 9:18am.

  9. Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  This research study uses special blood cells called multiple tumor-associated ...

    Clinical Trial last updated 04/28/2016 - 11:40am.

  10. A Study of PLX51107 in Advanced Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  The purpose of this research study is to evaluate safety, pharmacokinetics, pharmacodynamics, and ...

    Clinical Trial last updated 04/27/2016 - 2:09pm.